/ Photo: X / SpaceX
News·
SpaceX's earnings were more than double market expectations
For the first time since June 2025, the Wells Fargo indicator has issued a buy signal / Photo: Sheila Fitzgerald / Shutterstock.com
News·
The Wells Fargo indicator has issued a buy signal for the first time in nearly 1.5 years
AI model developers and the largest cloud companies are driving harder bargains with equipment suppliers / Photo: guentermanausl / Shutterstock.com
News·
AI giants are pushing for data center savings. Who stands to lose?
DeepSeek is opening up the software it uses to run its AI models at scale / Photo: Unsplash.com / Solen Feyissa
News·
DeepSeek open-sources tool to help cut AI operating costs
News·
‘Roller coaster’: What Wall Street expects from SpaceX third-quarter earnings
News·
Why Cathie Wood’s team expects Tesla stock to rise more than 1,000%
News·
"A Vicious Cycle": What Risks Does Rising Bond Yields Pose to the Stock Market?
News·
‘Weak link’: French sovereign risk premium approaches 15-year high
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Veradermics’ drug could become the first FDA-approved nonhormonal pill for male pattern hair loss, which affects around 50 mln men in the U.S. / Photo: Studio Romantic / Shutterstock
Small Caps·
Veradermics jumps on successful trial of its hair-loss pill. Is the stock a buy?
Small Caps·
Disc Medicine has best day in 4 years as its blood-disorder drug succeeds in trial
Small Caps·
+1
·
From PDFs to drone defense: How Finland’s newest billionaire built his business
Small Caps·
Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug
Small Caps·
Analysts see 35% upside in label maker Brady on data center demand and Honeywell deal
Go to section

Investment and Finance News